Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor

被引:24
|
作者
Tomoo, Koji [1 ]
机构
[1] Osaka Univ Pharmaceut Sci, Dept Phys Chem, Osaka 5691094, Japan
关键词
LYSOSOMAL CYSTEINE PROTEASES; RAY CRYSTAL-STRUCTURE; MALIGNANT PROGRESSION; OCCLUDING LOOP; PAPAIN; COMPLEX; BINDING; IDENTIFICATION; POTENT; E-64;
D O I
10.2174/156802610791113441
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cathepsins are a family of lysosomal cysteine proteases that are abundant in living cells and play important roles in intracellular proteolysis. Cathepsins are necessary for cell survival, and disruption of regulation of the activity of these enzymes causes serious diseases including allergy, atherosclerosis, muscular dystrophy, Alzheimer's disease and cancer. Therefore, the design of inhibitors for cathepsins is important in development of therapeutic agents. This review will focus on the features of the tertiary structure and substrate-binding specificity of cathepsins B, L, S and K, based on X-ray crystal structures of their complexes with inhibitors. To illustrate an approach to drug design, an example of structure-based design of a cathepsin B-specific inhibitor is described.
引用
收藏
页码:696 / 707
页数:12
相关论文
共 50 条
  • [1] Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex
    Yamamoto, A
    Tomoo, K
    Matsugi, K
    Hara, T
    In, Y
    Murata, M
    Kitamura, K
    Ishida, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2002, 1597 (02): : 244 - 251
  • [2] CRYSTAL-STRUCTURES OF RECOMBINANT RAT CATHEPSIN-B AND A CATHEPSIN B-INHIBITOR COMPLEX - IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN
    JIA, ZC
    HASNAIN, S
    HIRAMA, T
    LEE, X
    MORT, JS
    TO, R
    HUBER, CP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) : 5527 - 5533
  • [3] Combination of structure-based design and combinatorial chemistry for the development of cathepsin D inhibitors.
    Kick, EK
    Roe, DC
    Skillman, AD
    Liu, GC
    Ewing, TJA
    Sun, YX
    Kuntz, ID
    Ellman, JA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 67 - ORGN
  • [4] Structure-based design of orally bioavailable cathepsin K inhibitors.
    Thompson, SK
    Michaud, E
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Zhao, BG
    Smith, WW
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    Abdel-Meguid, SS
    Ijames, CF
    DesJarlais, RL
    Salyers, KL
    Smith, BR
    Levy, MA
    Veber, DF
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
  • [5] Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells
    Katunuma, N
    Tsuge, H
    Nukatsuka, M
    Asao, T
    Fukushima, M
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) : 305 - 311
  • [6] Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo
    Katunuma, N
    Matsui, A
    Inubushi, T
    Murata, E
    Kakegawa, H
    Ohba, Y
    Turk, D
    Turk, V
    Tada, Y
    Asao, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (03) : 850 - 854
  • [7] Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo
    Katunuma, N
    Murata, E
    Kakegawa, H
    Matsui, A
    Tsuzuki, H
    Tsuge, H
    Turk, D
    Turk, V
    Fukushima, M
    Tada, Y
    Asao, T
    [J]. FEBS LETTERS, 1999, 458 (01) : 6 - 10
  • [8] Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design
    Greenspan, PD
    Clark, KL
    Tommasi, RA
    Cowen, SD
    McQuire, LW
    Farley, DL
    van Duzer, JH
    Goldberg, RL
    Zhou, HH
    Du, ZM
    Fitt, JJ
    Coppa, DE
    Fang, Z
    Macchia, W
    Zhu, LJ
    Capparelli, MP
    Goldstein, R
    Wigg, AM
    Doughty, JR
    Bohacek, RS
    Knap, AK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4524 - 4534
  • [9] MOLECULAR DESIGN OF POTENT INHIBITOR SPECIFIC FOR CATHEPSIN-B BASED ON THE TERTIARY STRUCTURE PREDICTION
    SUMIYA, S
    YONEDA, T
    KITAMURA, K
    MURATA, M
    YOKOO, C
    TAMAI, M
    YAMAMOTO, A
    INOUE, M
    ISHIDA, T
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (02) : 299 - 303
  • [10] STRUCTURE-BASED DRUG DESIGN OF A NOVEL SERIES OF HUMAN CATHEPSIN D INHIBITORS.
    Lee, Angela Y.
    Majer, Pavel
    Gulnik, Sergei V.
    Collins, Jack
    Silva, Abelardo M.
    Bhat, Narayana T.
    Erickson, John W.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C205 - C205